Detalhe da pesquisa
1.
Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Brain
; 144(12): 3742-3755, 2021 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145880
2.
In vivo Brain Estrogen Receptor Expression By Neuroendocrine Aging And Relationships With Gray Matter Volume, Bio-Energetics, and Clinical Symptomatology.
Res Sq
; 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36909660
3.
Development, initial validation, and application of a visual read method for [18F]MK-6240 tau PET.
Alzheimers Dement (N Y)
; 9(1): e12372, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36873926
4.
Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
Alzheimers Dement (N Y)
; 8(1): e12325, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846158
5.
Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia.
Alzheimers Dement (N Y)
; 7(1): e12106, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614888
6.
Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.
Sci Rep
; 11(1): 10867, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108509
7.
Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
Neurology
; 95(2): e166-e178, 2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580974
8.
Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
BMJ Open
; 8(11): e023664, 2018 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478117
9.
FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease.
Neuroimage Clin
; 20: 572-579, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30186761
10.
Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.
BMJ Open
; 8(3): e019362, 2018 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574441
11.
Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.
Neurology
; 90(20): e1789-e1798, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653991
12.
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
J Alzheimers Dis
; 60(2): 439-450, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28946567
13.
Dissociation of Down syndrome and Alzheimer's disease effects with imaging.
Alzheimers Dement (N Y)
; 2(2): 69-81, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28642933
14.
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.
Curr Alzheimer Res
; 11(6): 564-73, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931567
15.
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study.
Adv J Mol Imaging
; 4(4): 43-57, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25599008
16.
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
J Alzheimers Dis
; 35(3): 509-24, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23478305
17.
D2-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D2-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection.
Psychopharmacology (Berl)
; 224(4): 549-57, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773165
18.
Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects.
Psychopharmacology (Berl)
; 208(1): 109-19, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19911168